Literature DB >> 10808372

BCL-6 in the pathogenesis of non-Hodgkin's lymphoma.

B H Ye1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10808372     DOI: 10.3109/07357900009012179

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  15 in total

1.  Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.

Authors:  Xing Wang; Zhiping Li; Akira Naganuma; B Hilda Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

2.  Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A.

Authors:  Angharad M Shore; Paul C White; Rosaline C-Y Hui; Abdelkader Essafi; Eric W-F Lam; Martin Rowe; Paul Brennan
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.

Authors:  B Belinda Ding; J Jessica Yu; Raymond Y-L Yu; Lourdes M Mendez; Rita Shaknovich; Yonghui Zhang; Giorgio Cattoretti; B Hilda Ye
Journal:  Blood       Date:  2007-10-19       Impact factor: 22.113

Review 4.  B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma.

Authors:  Weimin Ci; Jose M Polo; Ari Melnick
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

Review 5.  Hepatitis viruses and non-Hodgkin's lymphoma: A review.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Rudragoud S Policegoudra; Hemant K Gogoi; Lokendra Singh
Journal:  World J Virol       Date:  2012-12-12

6.  Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.

Authors:  Anshu Aggarwal; William J Hunter; Himanshu Aggarwal; Edibaldo D Silva; Mary S Davey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-21       Impact factor: 3.362

7.  A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.

Authors:  Leandro C Cerchietti; Alexandru F Ghetu; Xiao Zhu; Gustavo F Da Silva; Shijun Zhong; Marilyn Matthews; Karen L Bunting; Jose M Polo; Christophe Farès; Cheryl H Arrowsmith; Shao Ning Yang; Monica Garcia; Andrew Coop; Alexander D Mackerell; Gilbert G Privé; Ari Melnick
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

8.  Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.

Authors:  Ashwini S Phadnis-Moghe; Robert B Crawford; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2014-12-26       Impact factor: 4.849

9.  BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner.

Authors:  Stella Maris Ranuncolo; Ling Wang; Jose M Polo; Tania Dell'Oso; Jamil Dierov; Terry J Gaymes; Feyruz Rassool; Martin Carroll; Ari Melnick
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

10.  Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design.

Authors:  Huimin Cheng; Brian M Linhares; Wenbo Yu; Mariano G Cardenas; Yong Ai; Wenjuan Jiang; Alyssa Winkler; Sandra Cohen; Ari Melnick; Alexander MacKerell; Tomasz Cierpicki; Fengtian Xue
Journal:  J Med Chem       Date:  2018-07-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.